Table 2 Therapeutic effect of Cecropin B-LHRH’ on the volume of ES-2 tumors xenografted into nude mice (Mean ± SD)
From: Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells
Group | Dose (mg/kg.d) | Tumor Volume (mm3) | RTV | T/C (%) | |
|---|---|---|---|---|---|
d 1 | d 13 | ||||
CB-LHRH’ | 50 | 308.91 + 110.19 | 965.92 + 212.31** | 3.13 | 50 |
25 | 364.18 + 112.16 | 1334.78 + 179.25** | 3.67 | 59 | |
12.5 | 298.23 + 107.54 | 1416.71 + 353.71** | 4.75 | 76 | |
Cisplatin | 0.67 | 343.91 + 123.06 | 913.16 + 142.64** | 2.66 | 42 |
PBS | 326.56 + 85.00 | 2042.62 + 239.07 | 6.5 | – | |